Mark is a biotechnology R&D leader with expertise in live biotherapeutic drug development, mechanistic modeling, computational biology, and biomarker assay development. He is received a B.S. in microbiology from Michigan State University, before obtaining a PhD in computational and systems biology from Washington University in St. Louis in the lab of Jeffrey I. Gordon. Mark has held various roles of increasing responsibility in biotechnology organizations. Currently, Mark is the Vice President of Research and Development at Solarea Bio, a Massachusetts-based biotechnology company harnessing the untapped microbial diversity of fresh fruits and vegetables to create novel solutions to manage inflammatory diseases and enable people to lead long, healthy lives.